Zero Sperm Motility: When Does a Vitality Test Change the ICSI Plan?

“Zero motility” is frightening wording on a semen report, but motility and viability are different biological questions. A living sperm cell may fail to move under testing conditions. The laboratory’s method, collection interval and confirmation of the finding matter. Couples considering intracytoplasmic sperm injection (ICSI) should ask what information is actually available rather than assuming that no usable sperm exist.

Motility describes visible movement under laboratory assessment. Vitality examines whether cells are alive using methods selected by the andrology laboratory. These tests do not measure genetic normality or guarantee fertilisation, but they can help determine what further sperm selection is technically appropriate. An apparently immotile sample should not be managed solely from a printed percentage without information about concentration, morphology, volume and sample handling.

Long transport delays, temperature extremes, an unsuitable container or prolonged illness can complicate interpretation. Ask whether the original specimen was complete and evaluated within the lab’s validated interval. A clinician may request a second properly collected specimen because one result can vary. If repeated tests confirm severe immotility, a male-fertility assessment may seek reversible contributors or a more specific diagnosis.

ICSI introduces a selected sperm cell into an egg, but the embryologist needs a safe method for selecting a viable sperm when movement cannot be used as a signal. Different laboratories have validated protocols and limitations. Patients should ask whether appropriate methods are available before paying for an ICSI cycle. The decision to use fresh ejaculate or consider surgical retrieval belongs to the treating clinicians.

Even a confirmed severe male-factor result does not remove the need to review ovarian reserve, age, uterine anatomy and infection screening where appropriate. The couple may be offered a staged plan: confirm semen characteristics, assess reproductive health, then decide whether IUI is unsuitable or ICSI is proportionate. A fertility consultation should not interpret zero motility as automatic proof that pregnancy is impossible.

Ask for an itemised quote distinguishing routine IVF, ICSI, any additional laboratory sperm-selection procedure and contingency plans. Extra techniques should not be presented as universally proven improvements. Clarify whether sample freezing, an additional ejaculate or alternative retrieval requires consent, costs or procedure time. Avoid advertising claims promising fertilisation from any immotile specimen.

HomeIVF is a doctor-led fertility and IVF care-coordination model designed to reduce avoidable clinic journeys, not to relocate embryology into a living room. A medical review or follow-up discussion may be suitable for teleconsultation; selected home blood collection and prescription-based injection support are conditional on individual clinical suitability and confirmed local availability. Required ultrasound scans, sperm preparation, egg retrieval, fertilisation and embryo culture, and embryo transfer remain facility-based. A safe plan identifies the clinician and the facility responsible for every essential step.

Keep copies of both the initial and repeat semen reports and ask an andrologist to explain why vitality testing is appropriate. A teleconsultation may help coordinate questions, but any vitality testing, preparation, ICSI and possible retrieval must take place in an equipped facility. Seek timely in-person assessment for pain, swelling or other new symptoms.

When seeking another view, ask the new clinician to identify one or two decisions they might change and why. If the same treatment is recommended, the value can be reassurance based on the full record rather than the purchase of further testing. If a change is proposed, request evidence and an explanation of potential downsides. A good second opinion does not need to undermine the previous team to be useful.

Before the next appointment, agree on the responsible clinician, the result or symptom that should trigger contact, and the likely facility needed for examination. Keep emergency symptoms separate from routine messages; urgent care should never depend on a delayed remote reply. An agreed follow-up plan is especially important when the person lives far from the treatment centre or has changed providers mid-cycle.

Fertility decisions become easier when the clinician distinguishes what is required before the next cycle from what could be considered only if a future event occurs. Not every potential add-on should be purchased now. Storage, cancellation, additional investigations and later transfer can be disclosed as contingencies without assuming they will be needed. Patients deserve an understandable clinical sequence and the freedom to ask questions.

• Was immotility confirmed on a repeat, correctly handled sample?
• Is vitality testing indicated and validated here?
• How will viable sperm be selected for ICSI?
• What would make surgical sperm retrieval relevant?